Breaking away from a narrow prescribing protocol for medicinal nicotine.
Stapleton
John A
JA
Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College, London, UK. john.stapleton@iop.kcl.ac.uk
D000279:Administration, Cutaneous; D000328:Adult; D001552:Benzazepines / Q000008:administration & dosage*; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage*; D018722:Nicotinic Agonists / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care / Q000523:psychology; D011810:Quinoxalines / Q000008:administration & dosage*; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D009538:Nicotine; D000068580:Varenicline